Business Description
Carlsmed Inc
NAICS : 923120
SIC : 5045
ISIN : US14280C1053
Total Employee Number:
127Description
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.62 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.56 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 5.96 | |||||
Beneish M-Score | -2.15 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.65 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 42.33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.74 | |||||
9-Day RSI | 55.15 | |||||
14-Day RSI | 53.15 | |||||
3-1 Month Momentum % | 18.84 | |||||
6-1 Month Momentum % | -12.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.88 | |||||
Quick Ratio | 11.67 | |||||
Cash Ratio | 9.99 | |||||
Days Inventory | 40.64 | |||||
Days Sales Outstanding | 68.24 | |||||
Days Payable | 81.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.89 | |||||
Operating Margin % | -60.48 | |||||
Net Margin % | -57.76 | |||||
EBITDA Margin % | -54.71 | |||||
FCF Margin % | -62.29 | |||||
OCF Margin % | -59.94 | |||||
ROE % | -118.04 | |||||
ROA % | -32.94 | |||||
ROIC % | -263.05 | |||||
ROC (Joel Greenblatt) % | -388.41 | |||||
ROCE % | -35.31 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.53 | |||||
PB Ratio | 3.27 | |||||
Price-to-Tangible-Book | 3.27 | |||||
EV-to-EBIT | -7.1 | |||||
EV-to-EBITDA | -7.18 | |||||
EV-to-Revenue | 3.93 | |||||
EV-to-FCF | -6.31 | |||||
| Price-to-Net-Current-Asset-Value | 3.4 | |||||
| Price-to-Net-Cash | 4.28 | |||||
Earnings Yield (Greenblatt) % | -14.08 | |||||
FCF Yield % | -11.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CARL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Carlsmed Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 56.438 | ||
| EPS (TTM) ($) | -2.51 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 53.15 | ||
| 14-Day ATR ($) | 0.789823 | ||
| 20-Day SMA ($) | 10.9365 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 8.5 - 17.19 | ||
| Shares Outstanding (Mil) | 27.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Carlsmed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Carlsmed Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 13:30 | In 135 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 134 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-28 13:30 | In 65 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 64 days | ||
| General meeting for 2026 | 2026-06-03 08:00 | 10.17 (-8.21%) | ||
| First quarter earnings conference call for 2026 | 2026-05-05 13:30 | 9.09 (-3.09%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 9.09 (-3.09%) | ||
| 25th Annual Needham Virtual Healthcare Conference | 2026-04-13 11:45 | 8.94 (-6.88%) | ||
| Guidance call for 2026 | 2026-03-02 11:30 | 14.57 (+1.60%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-25 13:30 | 13.06 (+1.56%) |
Show
Entries
Carlsmed Inc Frequently Asked Questions
What is Carlsmed Inc(CARL)'s stock price today?
The current price of CARL is $11.09. The 52 week high of CARL is $17.19 and 52 week low is $8.50.
When is next earnings date of Carlsmed Inc(CARL)?
The next earnings date of Carlsmed Inc(CARL) is 2026-08-28 Est..
Does Carlsmed Inc(CARL) pay dividends? If so, how much?
Carlsmed Inc(CARL) does not pay dividend.
Guru Commentaries on NAS:CARL
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Carlsmed Announces Pricing of Initial Public Offering | 2025-07-22 | ||
| Carlsmed Announces Launch of Initial Public Offering | 2025-07-22 |
Articles on Carlsmed Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers